Primary Adenosquamous Carcinoma of the Prostate with Rectal Invasion

Prostate adenosquamous carcinoma (pASC) is a rare form of prostate cancer accounting for <1% of all cases. It is generally considered an aggressive variant often presenting with significant symptom burden and/or metastatic disease. Given its rarity, optimal management of this cancer is unknown. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Azzi, Pierre, Bossé, Dominique, Cagiannos, Ilias, Borowy-Borowski, Paul, Tiberi, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249496/
https://www.ncbi.nlm.nih.gov/pubmed/35782655
http://dx.doi.org/10.1155/2022/7613482
_version_ 1784739596440961024
author Azzi, Pierre
Bossé, Dominique
Cagiannos, Ilias
Borowy-Borowski, Paul
Tiberi, David
author_facet Azzi, Pierre
Bossé, Dominique
Cagiannos, Ilias
Borowy-Borowski, Paul
Tiberi, David
author_sort Azzi, Pierre
collection PubMed
description Prostate adenosquamous carcinoma (pASC) is a rare form of prostate cancer accounting for <1% of all cases. It is generally considered an aggressive variant often presenting with significant symptom burden and/or metastatic disease. Given its rarity, optimal management of this cancer is unknown. We present a case of a patient with pASC treated with radiotherapy and chemotherapy with excellent symptomatic improvement and local control.
format Online
Article
Text
id pubmed-9249496
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-92494962022-07-02 Primary Adenosquamous Carcinoma of the Prostate with Rectal Invasion Azzi, Pierre Bossé, Dominique Cagiannos, Ilias Borowy-Borowski, Paul Tiberi, David Case Rep Urol Case Report Prostate adenosquamous carcinoma (pASC) is a rare form of prostate cancer accounting for <1% of all cases. It is generally considered an aggressive variant often presenting with significant symptom burden and/or metastatic disease. Given its rarity, optimal management of this cancer is unknown. We present a case of a patient with pASC treated with radiotherapy and chemotherapy with excellent symptomatic improvement and local control. Hindawi 2022-06-24 /pmc/articles/PMC9249496/ /pubmed/35782655 http://dx.doi.org/10.1155/2022/7613482 Text en Copyright © 2022 Pierre Azzi et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Azzi, Pierre
Bossé, Dominique
Cagiannos, Ilias
Borowy-Borowski, Paul
Tiberi, David
Primary Adenosquamous Carcinoma of the Prostate with Rectal Invasion
title Primary Adenosquamous Carcinoma of the Prostate with Rectal Invasion
title_full Primary Adenosquamous Carcinoma of the Prostate with Rectal Invasion
title_fullStr Primary Adenosquamous Carcinoma of the Prostate with Rectal Invasion
title_full_unstemmed Primary Adenosquamous Carcinoma of the Prostate with Rectal Invasion
title_short Primary Adenosquamous Carcinoma of the Prostate with Rectal Invasion
title_sort primary adenosquamous carcinoma of the prostate with rectal invasion
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249496/
https://www.ncbi.nlm.nih.gov/pubmed/35782655
http://dx.doi.org/10.1155/2022/7613482
work_keys_str_mv AT azzipierre primaryadenosquamouscarcinomaoftheprostatewithrectalinvasion
AT bossedominique primaryadenosquamouscarcinomaoftheprostatewithrectalinvasion
AT cagiannosilias primaryadenosquamouscarcinomaoftheprostatewithrectalinvasion
AT borowyborowskipaul primaryadenosquamouscarcinomaoftheprostatewithrectalinvasion
AT tiberidavid primaryadenosquamouscarcinomaoftheprostatewithrectalinvasion

Ejemplares similares